CN106606736A - Traditional Chinese medicine used for treating hyperplasia of mammary glands - Google Patents
Traditional Chinese medicine used for treating hyperplasia of mammary glands Download PDFInfo
- Publication number
- CN106606736A CN106606736A CN201510688057.XA CN201510688057A CN106606736A CN 106606736 A CN106606736 A CN 106606736A CN 201510688057 A CN201510688057 A CN 201510688057A CN 106606736 A CN106606736 A CN 106606736A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- radix
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine used for treating hyperplasia of mammary glands. The traditional Chinese medicine is prepared from, by weight, 10 to 20 parts of fruit of fiverleaf akebia, 10 to 20 parts of cornu cervi degelatinatum, 15 to 25 parts of radix salviae miltiorrhizae, 10 to 18 parts of spina gleditsiae, 15 to 25 parts of prunella vulgaris, 15 to 25 parts of radix curcumae, 10 to 20 parts of semen vaccariae, 12 to 20 parts of flowers carthami, 10 to 20 parts of rhizoma curcumae, 10 to 18 parts of angelica sinensis, 10 to 20 parts of concha ostreae, 15 to 25 parts of anise, and 15 to 25 parts of fennel. Clinical observation of application of the traditional Chinese medicine is carried out for a plurality of years, 100 patients with hyperplasia of mammary glands are selected for clinical experiment, after eating of the traditional Chinese medicine for 3 months, clinical curing of 61 patients is realized, clinical curing rate is 61%, 37 cases are markedly effective, markedly effective rate is 37%, and 2 cases are noneffective. It is confirmed by testing that remarkable effect is achieved in about 2 weeks of drug using, symptoms disappear or decrease after 2 months of drug using, total effective rate is 98%, and relapse is not easily caused.
Description
Technical field
The present invention relates to a kind of Chinese medicine for treating cyclomastopathy, belongs to field of pharmaceutical technology.
Background technology
Cyclomastopathy is the modal cystic hyperplasia of breast of women, and its sickness rate accounts for the first place of mastopathy.It is near
Over year, the sick sickness rate in the trend for rising year by year, also increasingly become younger by the age.In adolescence or youth
In women, it is premenstrual have distending pain of the breast, sometimes pain can involve shoulder back, Jing rear udder attachments pain is gradually voluntarily
Alleviate, be only capable of contacting mammary gland and thicken a bit, without obvious tuberosity, these are that physiology is sexually revised, and are not diseases,
Also without treatment, belong to physiological hypertrophy.Cyclomastopathy is normal breast lobule physiological hypertrophy
With subinvolution, mammary gland normal configuration gets muddled, and belongs to pathological proliferation, and it is not only noninflammatory but also non-
The one class disease of tumor.30-50 year women is mainly in, onset peak is 35-40 year due to cyclomastopathy
The mechanism and the cause of disease of generation there is no and have any actual knowledge of, and be essentially symptomatic treatment at present in treatment.Some patients send out
After several months to 1~2 year after being ill often can spontaneous remission, be not required to more treatment.Pathologic cyclomastopathy,
Active treatment is needed, especially cystic hyperplasia type, due to the possibility that there is canceration, it is impossible to adopt a casual attitude.
Western medicine cyclomastopathy is to adjust ovarian endocrine or blocking hormonal action target spot, blocking morbidity ring
Section, relief of symptoms, therefore it is many using the therapeutic scheme for suppressing estrogen drugs, although at the beginning of hormone therapy
Phase effect is pretty good, but as the amount and application time of input hormone during treatment are difficult snugly to be adapted to
The needs of primary disease, often have the disadvantage exceeded the proper limits in righting a wrong;Misapplication, more will certainly increase this unbalance
State.
The content of the invention
It is an object of the present invention to provide a kind of Chinese medicine for treating cyclomastopathy.The medication effect shows
Write, and recurrence is difficult after treating, and is had no toxic side effect.
Technical scheme:A kind of Chinese medicine for treating cyclomastopathy, the medicine is by following composition by weight
The raw material of ratio:10-20 parts of Fructus Akebiae, 10-20 parts of Cornu Cervi Degelatinatum, 15-25 parts of Radix Salviae Miltiorrhizae, Spina Gleditsiae
10-18 parts, 15-25 parts of Spica Prunellae, 15-25 parts of Radix Curcumae, 10-20 parts of Semen Vaccariae, Flos Carthami
12-20 parts, 10-20 parts of Rhizoma Curcumae, 10-18 parts of Radix Angelicae Sinensis, 10-20 parts of Concha Ostreae, Fructus Anisi Stellati 15-
25 parts, 15-25 parts of Fructus Foeniculi makes.
The Chinese medicine of aforesaid treatment cyclomastopathy, raw material of the medicine by following composition by weight ratio:Fructus Akebiae
13-17 parts, 13-17 parts of Cornu Cervi Degelatinatum, 18-22 parts of Radix Salviae Miltiorrhizae, 13-15 parts of Spina Gleditsiae, Spica Prunellae 18-
22 parts, 18-22 parts of Radix Curcumae, 14-18 parts of Semen Vaccariae, 15-17 parts of Flos Carthami, 13-17 parts of Rhizoma Curcumae,
13-15 parts of Radix Angelicae Sinensis, 13-17 parts of Concha Ostreae, 18-21 parts of Fructus Anisi Stellati, 18-21 parts of Fructus Foeniculi are made.
The Chinese medicine of aforesaid treatment cyclomastopathy, raw material of the medicine by following composition by weight ratio:Fructus Akebiae
15 parts, 15 parts of Cornu Cervi Degelatinatum, 20 parts of Radix Salviae Miltiorrhizae, 14 parts of Spina Gleditsiae, 20 parts of Spica Prunellae, 20 parts of Radix Curcumae, king not
Stay 16 parts of row, 16 parts of Flos Carthami, 15 parts of Rhizoma Curcumae, 14 parts of Radix Angelicae Sinensis, 15 parts of Concha Ostreae, 20 parts of Fructus Anisi Stellati, Fructus Foeniculi
Fragrant 20 parts are made.
Wherein:Fructus Akebiae:For liver-smoothing, qi-regulating, promoting blood circulation and stopping pain, relieving restlessness diuresis.Control stomachache due to hyperactive liver-QI attacking the stomach, stomach
Warm-served food is stayed, excessive thirst, dysentery, lumbago, Fructus Akebiae hypochondriac pain, hernia, dysmenorrhea, uterus tenesmus.
Cornu Cervi Degelatinatum:Cure mainly insufficiency of kidney-YANG, chills and pain of the waist and kness, impotence and seminal emission, frequent urination and enuresis;Deficiency and coldness of spleen and stomach,
Anorexia and loose stool, bleeding not during menses, wound hemorrhage, the long disunion of skin infection.
Radix Salviae Miltiorrhizae:Enter the heart, Liver Channel, with promoting blood circulation to remove blood stasis, detumescence hemostasis, menstruction regulating and pain relieving, relieving restlessness that clears away heart-fire,
The effect of cool blood to disappear carbuncle;For lump in the abdomen, hot numbness pain, dysphoria and insomnia, menoxenia, dysmenorrhea Jing
Close, sore swell and ache curative.
Spina Gleditsiae:Enter lung, Liver Channel, control swollen ulcer drug, scrofula, sore rash stubborn dermatitis, leprosy;Modern anticancer
Pharmacological research shows that Spina Gleditsiae has anticancer tumor-suppression activity.
Spica Prunellae:Return liver, gallbladder meridian, liver heat removing and eyesight improving, powder detoxifcation;Cure mainly scrofula, goiter, acute mastitis,
Carbuncle furuncle poison.
Radix Curcumae:Return liver, the heart, lung meridian, can promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, the removing heat from blood that clears away heart-fire, promoting the function of the gallbladder to alleviate jaundice.
Semen Vaccariae:Hardship, puts down.Return liver, stomach.Promoting the circulation of blood regulating menstruation, reducing swelling and alleviating pain, logical breast of promoting blood circulation, urge
Give birth to breast, thymus dredging in puerperal.Cure mainly blood stasis is through closing, dysmenorrhea, difficult labour;Lack of lactation after delivery, breast
Carbuncle and painful swelling;Pyretic stranguria, stranguria with blood, stranguria caused by urinary stone.
Flos Carthami:GUIXIN, Liver Channel, promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing;For amenorrhea, dysmenorrhea, lochia,
Abdominal mass lump in the abdomen, traumatic injury, swelling and pain of hemorrhoid.
Rhizoma Curcumae:Cure mainly blood-breaking pain relieving, removing blood stasis, women's amenorrhea, promoting the circulation of QI to relieve pain.
Radix Angelicae Sinensis:Return liver, the heart, spleen channel;Enrich blood, invigorate blood circulation, menstruction regulating and pain relieving, moisturize laxation;Cure mainly blood deficiency
All cards, menoxenia, amenorrhea, dysmenorrhea, poly- lump in the abdomen knot, metrorrhagia, asthenia cold abdominalgia, flaccidity syndrome and arthralgia syndrome, skin fiber crops
Wood, intestines are dry and shit is difficult, ulcer sores.
Concha Ostreae:It is salty, it is slightly cold.Return liver, gallbladder, kidney channel.Suppressing the hyperactive liver and subsiding YANG;Tranquillization with heavy prescription;Hard masses softening and resolving;
Convergence is astringent or styptic treatment for spontaneous sweating.Cure mainly vertigo and tinnitus;Insomnia of palpitating with fear;Scrofula goiter;Abdominal mass lump in the abdomen;Spontaneous sweating;Lose
Essence;Metrorrhagia;Leukorrhagia.
Fructus Anisi Stellati:Temperature;It is pungent;Return liver,kidney,spleen, stomach.Warming YANG to expel cold, regulating QI to relieve pain.For trembling with fear
Hernia is suffered from abdominal pain, lumbago due to renal deficiency, gastrofrigid vomiting, coldness and pain in the epigastrium.
Fructus Foeniculi:Acrid in the mouth, it is warm in nature.Enter kidney, bladder, stomach.Stimulating appetite, qi-regulating cold expelling, helps
Yang Dao.Cure mainly:Cold in middle-JIAO, loss of appetite, nausea and vomiting, abdominal part cold type of pain;Hernia pain, testis
Swell and ache;Stagnation of QI in spleen and stomach, distension and fullness in the abdomen are had a pain.
Clinical practice example of the present invention is as follows:
Case 1, patient Yin certain, female, 37 years old, on January 13rd, 2014 go to a doctor.Left breast lump pain
More than 2 months is unilateral cyclomastopathy on inspection, breast tuberosity.The medicine of the present invention is taken, after 2 weeks,
Pain relief;Continue after taking 2 months, tuberosity dissipates, pain disappears, and follow-up is not recurred for 1 year.
Case 2, patient Hu, female 34 years old, go to a doctor on 2 17th, 2014.Bilateral lump in breast pain
More than 1 month, increase with menstrual cycle, check as bilateral breast hypertrophy.The Chinese medicine of the present invention is taken,
After taking medicine 1 week, pain relief continues after taking 1 month, and lump dissipates, pain disappears, and follow-up is not answered for 1 year
Send out.
Case 3, patient Zeng, female 33 years old, go to a doctor on 2 23rd, 2014.Bilateral mastalgia 1
More than month, increase with menstrual cycle;Check as bilateral breast hypertrophy.Take the Chinese medicine of the present invention, medication
After 1 week, pain relief continues after taking 1 month, and pain disappears, and follow-up is not recurred for 1 year.
Beneficial effects of the present invention:The Chinese medicine of the treatment cyclomastopathy of the present invention, can dispersing liver and promoting blood circulation, softening the hard mass
Eliminating stagnation, reducing swelling and alleviating pain;Cyclomastopathy depressed for stagnation of liver-QI, caused by qi depression to blood stasis, nodule in the breast tuberosity,
Distending pain;Rationally, compatibility is original, evident in efficacy for its scientific formula;Have treating both the principal and secondary aspects of a disease, have no toxic side effect,
The features such as instant effect, difficulty in relapse after healing, be treatment cyclomastopathy, the good medicine of nodule in the breast tuberosity.
Criterion of therapeutical effect:
It is effective:Symptom disappears, and lump in breast disappears or reduction more than 50%, and drug withdrawal is not recurred for 3 months.
Effectively:Clinical symptom disappearance, lump in breast reduce.
It is invalid:Mastalgia, lump are not reduced.
The medicine Jing clinical observations of many years of the present invention, select proliferation of mammary gland patient 100;Medication 3
Count after month, clinical cure 61 accounts for 61%;Effective 37, account for 37%;Invalid 2;After testing
Checking, 2 weeks or so effect is significants of taking medicine, after 2 months, symptom disappears or mitigates;Total effective rate is 98%,
And it is difficult recurrence.
Specific embodiment
With reference to embodiment, the present invention is further illustrated, but is not intended as what the present invention was limited
Foundation.
Embodiments of the invention 1:A kind of Chinese medicine for treating cyclomastopathy, the medicine is by following composition by weight
The raw material of ratio:10 parts of Fructus Akebiae, 10 parts of Cornu Cervi Degelatinatum, 15 parts of Radix Salviae Miltiorrhizae, 10 parts of Spina Gleditsiae, Spica Prunellae
15 parts, 15 parts of Radix Curcumae, 10 parts of Semen Vaccariae, 12 parts of Flos Carthami, 10 parts of Rhizoma Curcumae, 10 parts of Radix Angelicae Sinensis,
10 parts of Concha Ostreae, 15 parts of Fructus Anisi Stellati, 15 parts of Fructus Foeniculi are made.
Embodiments of the invention 2:A kind of Chinese medicine for treating cyclomastopathy, the medicine is by following composition by weight
The raw material of ratio:20 parts of Fructus Akebiae, 20 parts of Cornu Cervi Degelatinatum, 25 parts of Radix Salviae Miltiorrhizae, 18 parts of Spina Gleditsiae, Spica Prunellae
25 parts, 25 parts of Radix Curcumae, 20 parts of Semen Vaccariae, 20 parts of Flos Carthami, 20 parts of Rhizoma Curcumae, 18 parts of Radix Angelicae Sinensis,
20 parts of Concha Ostreae, 25 parts of Fructus Anisi Stellati, 25 parts of Fructus Foeniculi are made.
Embodiments of the invention 3:A kind of Chinese medicine for treating cyclomastopathy, the medicine is by following composition by weight
The raw material of ratio:15 parts of Fructus Akebiae, 15 parts of Cornu Cervi Degelatinatum, 20 parts of Radix Salviae Miltiorrhizae, 14 parts of Spina Gleditsiae, 20 parts of Spica Prunellae,
It is 20 parts of Radix Curcumae, 16 parts of Semen Vaccariae, 16 parts of Flos Carthami, 15 parts of Rhizoma Curcumae, 14 parts of Radix Angelicae Sinensis, 15 parts of Concha Ostreae, big
20 parts of Fructus Foeniculi, 20 parts of Fructus Foeniculi are made.
When the medicine of above example makes, by medicament mixed, dry, be ground into the thin of 100 mesh or so
Powder, adds and the refined honey that medicated powder weight ratio is 1: 1, mix homogeneously, bar processed, with 5 grams/ball pelletization, honeybee
Seal with wax and deposit.
Instructions of taking:Orally, the daily morning and evening is each once, and a ball, is taken with boiled water every time.
Above the specific descriptions of the present invention are intended to illustrate the implementation of specific embodiment, it is impossible to understand
To be limitation of the present invention.Those of ordinary skill in the art under the teachings of the present invention, can describe in detail
Embodiment on the basis of make various variants, these variants should be included in the present invention design it
It is interior.Scope of the present invention is only limited by described claims.
Claims (3)
1. a kind of Chinese medicine for treating cyclomastopathy, it is characterised in that:The medicine is by following composition by weight ratio
Raw material:10-20 parts of Fructus Akebiae, 10-20 parts of Cornu Cervi Degelatinatum, 15-25 parts of Radix Salviae Miltiorrhizae, Spina Gleditsiae 10-18
Part, 15-25 parts of Spica Prunellae, 15-25 parts of Radix Curcumae, 10-20 parts of Semen Vaccariae, 12-20 parts of Flos Carthami,
10-20 parts of Rhizoma Curcumae, 10-18 parts of Radix Angelicae Sinensis, 10-20 parts of Concha Ostreae, 15-25 parts of Fructus Anisi Stellati, Fructus Foeniculi 15
- 25 parts are made.
2. it is according to claim 1 treatment cyclomastopathy Chinese medicine, it is characterised in that:The medicine by
The raw material of following composition by weight ratio:13-17 parts of Fructus Akebiae, 13-17 parts of Cornu Cervi Degelatinatum, 18-22 parts of Radix Salviae Miltiorrhizae,
It is 13-15 parts of Spina Gleditsiae, 18-22 parts of Spica Prunellae, 18-22 parts of Radix Curcumae, 14-18 parts of Semen Vaccariae, red
Spend 15-17 parts, 13-17 parts of Rhizoma Curcumae, 13-15 parts of Radix Angelicae Sinensis, 13-17 parts of Concha Ostreae, Fructus Anisi Stellati 18-21
Part, 18-21 parts of Fructus Foeniculi are made.
3. it is according to claim 2 treatment cyclomastopathy Chinese medicine, it is characterised in that:The medicine by
The raw material of following composition by weight ratio:15 parts of Fructus Akebiae, 15 parts of Cornu Cervi Degelatinatum, 20 parts of Radix Salviae Miltiorrhizae, 14 parts of Spina Gleditsiae,
20 parts of Spica Prunellae, 20 parts of Radix Curcumae, 16 parts of Semen Vaccariae, 16 parts of Flos Carthami, 15 parts of Rhizoma Curcumae, 14 parts of Radix Angelicae Sinensis,
15 parts of Concha Ostreae, 20 parts of Fructus Anisi Stellati, 20 parts of Fructus Foeniculi are made.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510688057.XA CN106606736A (en) | 2015-10-21 | 2015-10-21 | Traditional Chinese medicine used for treating hyperplasia of mammary glands |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510688057.XA CN106606736A (en) | 2015-10-21 | 2015-10-21 | Traditional Chinese medicine used for treating hyperplasia of mammary glands |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106606736A true CN106606736A (en) | 2017-05-03 |
Family
ID=58611488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510688057.XA Pending CN106606736A (en) | 2015-10-21 | 2015-10-21 | Traditional Chinese medicine used for treating hyperplasia of mammary glands |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106606736A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107898976A (en) * | 2017-12-25 | 2018-04-13 | 侯马高知新生物科技有限公司 | A kind of Chinese medicine for treating the proliferation of mammary gland |
-
2015
- 2015-10-21 CN CN201510688057.XA patent/CN106606736A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107898976A (en) * | 2017-12-25 | 2018-04-13 | 侯马高知新生物科技有限公司 | A kind of Chinese medicine for treating the proliferation of mammary gland |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101766773B (en) | Chinese medicine prescription for treating talagia | |
CN101703651B (en) | Medicament for treating diabetic gangrene | |
CN101190310B (en) | Traditional Chinese medicine composition for treating mazopathy | |
GB2497926A (en) | Drug treating high blood pressure | |
CN102335309A (en) | Formula of ointment for treating burns and scalds | |
CN104873851A (en) | Internal and external traditional-Chinese-medicine composition for treating bedsore | |
CN100352483C (en) | Externally applied medicine for treating mammary glands hyperplasia and preventing mammary cancer | |
CN106606736A (en) | Traditional Chinese medicine used for treating hyperplasia of mammary glands | |
CN108144032A (en) | A pharmaceutical composition for treating female infertility, promoting blood circulation and removing blood stasis, and its preparation method and treatment method | |
CN104958693B (en) | Treat the Chinese medicine of the proliferation of mammary gland | |
CN103656525A (en) | Traditional Chinese medicinal composition for treating dysmenorrhea | |
CN104666707A (en) | Traditional Chinese medicine capable of regulating menstruation to stop pain | |
CN101513518B (en) | Chinese medicinal composition for treating mammary gland hyperplasia | |
CN101554449B (en) | Traditional Chinese medicine for traumatic curing | |
CN106606735A (en) | Medicine for treating proliferation of mammary glands | |
CN106581570A (en) | Cyclomastopathy treating traditional Chinese medicine | |
CN113262264A (en) | A Chinese medicinal composition for relieving pain and promoting granulation, and its preparation method | |
CN103893328B (en) | Traditional Chinese medicine pill used for treating hyperplasia of mammary glands | |
CN106039151A (en) | External use ointment for treating hyperplasia of mammary glands | |
CN104815101A (en) | Externally used medicine for treating climacteric syndrome and preparation method thereof | |
CN106581571A (en) | Medicine for treating hyperplasia of mammary glands | |
CN106421632A (en) | Traditional Chinese medicine composition for curing gynecological disease | |
CN104666708A (en) | Traditional Chinese medicine for treating dysmenorrhea of women | |
CN105168657A (en) | Traditional Chinese medicine ointment for treating haemorrhoids | |
CN117257864A (en) | Traditional Chinese medicine composition and preparation for treating uterine cold stagnation type irregular menstruation as well as preparation method and application of traditional Chinese medicine composition and preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170503 |